MARKET

CPHRF

CPHRF

Cipher Phrmctcls
OTCQX
12.25
0.00
0.00%
Closed 10:00 05/22 EDT
OPEN
12.25
PREV CLOSE
12.25
HIGH
12.25
LOW
12.25
VOLUME
370
TURNOVER
4.53K
52 WEEK HIGH
15.00
52 WEEK LOW
8.60
MARKET CAP
293.86M
P/E (TTM)
10.29
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CPHRF last week (0511-0515)?
Weekly Report · 5d ago
Cipher Pharmaceuticals price target raised to C$22 from C$21 at Stifel
TipRanks · 05/13 18:07
CANADA RESEARCH ROUNDUP-Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Reuters · 05/12 10:30
CIPHER PHARMACEUTICALS INC <CPH.TO>: CANACCORD GENUITY RESUMES COVERAGE WITH HOLD RATING; TARGET PRICE C$17
Reuters · 05/12 03:25
Stifel Nicolaus Remains a Buy on Cipher Pharmaceuticals (CPHRF)
TipRanks · 05/11 13:28
Weekly Report: what happened at CPHRF last week (0504-0508)?
Weekly Report · 05/11 09:29
Cipher Q1 FY26 net income more than doubles to $6.2 million; revenue rises 4% to $12.5 million
PUBT · 05/07 22:02
Cipher Pharmaceuticals GAAP EPS of $0.24 beats by $0.10, revenue of $12.51M beats by $0.31M
Seeking Alpha · 05/07 21:52
More
About CPHRF
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.

Webull offers Cipher Pharmaceuticals Inc stock information, including OTCQX: CPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPHRF stock methods without spending real money on the virtual paper trading platform.